Paxil paroxetine regulatory update

GlaxoSmithKline disclosed in its 4Q13 earnings that Japan approved Paxil paroxetine to treat post-traumatic stress disorder (PTSD). The selective serotonin reuptake inhibitor (SSRI) is approved for PT...